This workshop will examine how next day automated NGS technology is being leveraged to accelerate genomic profiling in myeloid malignancies research—helping to support timely insights. The workshop will also highlight the use of the Oncomine™ TCR Pan-Clonality Assay for evaluating immune repertoires in T-cell lymphoma samples, with applications in clonality assessment and detection of measurable residual disease (MRD). Discussions will emphasize how these approaches align with current testing frameworks and expand the utility of NGS in hematologic research.
